RE: So if the molecular analysis Co's that analyse the patients dead23 Sep 2023 12:37
Find the presentation here:-
https://angleplc.com/investor-relations/corporate-presentations/
Doc83.
Until a company is firmly established of course there are risks. Even established Co's can fail. Think Enron!
The question is do you believe Angle will come good?
I like the fact that we have seen the management are not afraid to take the tough decisions including shutting down their operations in Toronto, Canada because they were too expensive Compared to the UK and USA ones in October 2022.
I think the Parsortix machine is a "must have" for research into cancer. I think sales of the machines and the associated consumables will continue for years to come.
The assays (test kits) Angle are developing will drive the sales of the machines and consumables.
For example I think the HER2 assay kit for monitoring Breast cancer will be a game changer on it's own for Angle.
Once the HER2 assay kit is available clinics treating breast cancer will need to have the Parsortix machine to monitor the patients HER2 status. I understand this status can be positive or negative. Unfortunately this status can change over time. HER2 positive breast cancer item from the internet:-
"These cancers tend to grow and spread faster than breast cancers that are HER2-negative, but are much more likely to respond to treatment with drugs that target the HER2 protein.".
So it is vital a patients HER2 status is monitored so the most effective treatment can be given.
From the RNS dated 29th April 2023:-
"ANGLE plc (AIM: AGL; OTCQX: ANPCY), a world-leading liquid biopsy company, is delighted to announce it has signed an agreement with BioView Ltd. ("BioView") (BIOV.TA) to develop a liquid biopsy circulating tumor cell (CTC) HER2 assay for breast cancer utilising ANGLE's FDA cleared Parsortix(R) PC1 Clinical System to harvest CTCs and BioView's automated microscopy systems and software to detect and assess the HER2 expression and/or gene amplification in CTCs. ".
In the presentation they said this will be offered first from Angle's labs, then an assay kit. The kit should see sales of the machine take off.
This is just ONE of the assays (tests) they are developing. Some are already available let's not forget.
Angle's future looks very good to me.
Do your own research and make your own mind up.
All IMHO.